Journey Medical Corp Director's Stock Grant

On August 5, 2025, Michael Cooper Pearce, a director of Journey Medical Corp, was granted 20,000 restricted stock units under the company's 2015 Stock Plan, as amended. These units will vest in three installments: 6,667 shares on August 5, 2028, 6,667 shares on August 5, 2029, and 6,666 shares on August 5, 2030. Following this transaction, Pearce owns a total of 57,173 shares of common stock, including previously granted restricted stock units that vest over various periods. The transaction was reported in a Form 4 filing with the SEC.